| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And CEO | President &CEO | Head Of Research &Development +4 more
2 companies
Sandrock Alfred is a President And CEO at VYGR with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $4.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 27, 2018 | BIIB Biogen Inc. | EVP, Chief Medical Officer | Sell | 259 | $290.83 | $75,324.97 | -3.8% | |
| Feb 23, 2018 | BIIB Biogen Inc. | EVP, Chief Medical Officer | Sale+OE | 908 | $293.44 | $266,443.52 | -12.2% | |
| Feb 20, 2018 | BIIB Biogen Inc. | EVP, Chief Medical Officer | Sell | 743 | $292.00 | $216,956.00 | -10.2% | |
| Feb 15, 2018 | BIIB Biogen Inc. | EVP, Chief Medical Officer | Sell | 1,294 | $298.85 | $386,711.90 | -15.1% | |
| Apr 3, 2017 | BIIB Biogen Inc. | EVP CMO Neuro &Neurodegenerat | Sell | 1,981 | $274.08 | $542,952.48 | -21.9% | |
| Mar 1, 2017 | BIIB Biogen Inc. | EVP CMO Neuro &Neurodegenerat | Sell | 973 | $290.07 | $282,238.11 | -9.7% | |
| Feb 25, 2016 | BIIB Biogen Inc. | EVP CMO Neuro &Neurodegenerat | Sell | 183 | $261.90 | $47,927.70 | -2.2% | |
| Feb 17, 2016 | BIIB Biogen Inc. | EVP CMO Neuro &Neurodegenerat | Sell | 722 | $256.16 | $184,947.52 | -8.3% | |
| Feb 9, 2016 | BIIB Biogen Inc. | EVP CMO Neuro &Neurodegenerat | Sale+OE | 852 | $246.54 | $210,052.08 | -9.9% | |
| Dec 4, 2015 | BIIB Biogen Inc. | EVP CMO Neuro &Neurodegenerat | Sell | 441 | $277.00 | $122,157.00 | -5.4% |